A comparative study of three Aloe species used to treat skin diseases in South African rural communities. 2013

Roger M Coopoosamy, and Kuben K Naidoo
Department of Nature Conservation, Mangosuthu University of Technology, Durban, KwaZulu-Natal, South Africa. rogercoopoosamy@gmail.com

OBJECTIVE Aloe species have been noted to be a miracle cure used by indigenous people of southern Africa. Geographically, each of the three Aloe species-Aloe arborescens, Aloe excelsa, and Aloe ferox-has a specific habitat. Although some species overlap in geographical regions, the species most abundant in a region is most often utilized by indigenous people. All three species display similar curative properties, aiding in wound healing, cures against other skin ailments, and some systemic conditions. RESULTS All three Aloe species indicated high inhibitory activity against all gram-positive bacteria under investigation. The ethanol extract was most effective and inhibited all gram-positive bacteria and two gram-negative bacteria (i.e., Proteus vulgaris and Escherichia coli). CONCLUSIONS All fungal species under investigation were successfully inhibited by both the boiled water as well as the ethanol extract, substantiating the traditional usage of this species.

UI MeSH Term Description Entries
D008517 Phytotherapy Use of plants or herbs to treat diseases or to alleviate pain. Herb Therapy,Herbal Therapy
D008826 Microbial Sensitivity Tests Any tests that demonstrate the relative efficacy of different chemotherapeutic agents against specific microorganisms (i.e., bacteria, fungi, viruses). Bacterial Sensitivity Tests,Drug Sensitivity Assay, Microbial,Minimum Inhibitory Concentration,Antibacterial Susceptibility Breakpoint Determination,Antibiogram,Antimicrobial Susceptibility Breakpoint Determination,Bacterial Sensitivity Test,Breakpoint Determination, Antibacterial Susceptibility,Breakpoint Determination, Antimicrobial Susceptibility,Fungal Drug Sensitivity Tests,Fungus Drug Sensitivity Tests,Sensitivity Test, Bacterial,Sensitivity Tests, Bacterial,Test, Bacterial Sensitivity,Tests, Bacterial Sensitivity,Viral Drug Sensitivity Tests,Virus Drug Sensitivity Tests,Antibiograms,Concentration, Minimum Inhibitory,Concentrations, Minimum Inhibitory,Inhibitory Concentration, Minimum,Inhibitory Concentrations, Minimum,Microbial Sensitivity Test,Minimum Inhibitory Concentrations,Sensitivity Test, Microbial,Sensitivity Tests, Microbial,Test, Microbial Sensitivity,Tests, Microbial Sensitivity
D010936 Plant Extracts Concentrated pharmaceutical preparations of plants obtained by removing active constituents with a suitable solvent, which is evaporated away, and adjusting the residue to a prescribed standard. Herbal Medicines,Plant Extract,Extract, Plant,Extracts, Plant,Medicines, Herbal
D011512 Proteus Infections Infections with bacteria of the genus PROTEUS. Infections, Proteus,Infection, Proteus,Proteus Infection
D011514 Proteus vulgaris A species of gram-negative, facultatively anaerobic, rod-shaped bacteria that occurs in soil, fecal matter, and sewage. It is an opportunistic pathogen and causes cystitis and pyelonephritis.
D003881 Dermatomycoses Superficial infections of the skin or its appendages by any of various fungi. Skin Diseases, Fungal,Dermatomycosis,Dermatophyte Infection,Fungal Skin Diseases
D003906 Developing Countries Countries in the process of change with economic growth, that is, an increase in production, per capita consumption, and income. The process of economic growth involves better utilization of natural and human resources, which results in a change in the social, political, and economic structures. LMICs,Less-Developed Countries,Low Income Countries,Low and Middle Income Countries,Lower-Middle-Income Country,Middle Income Countries,Third-World Countries,Under-Developed Countries,Developing Nations,Least Developed Countries,Less-Developed Nations,Third-World Nations,Under-Developed Nations,Countries, Middle Income,Countries, Third-World,Country, Least Developed,Country, Less-Developed,Country, Low Income,Country, Lower-Middle-Income,Country, Middle Income,Country, Third-World,Country, Under-Developed,Developed Country, Least,Developing Country,Developing Nation,Least Developed Country,Less Developed Countries,Less Developed Nations,Less-Developed Country,Less-Developed Nation,Low Income Country,Lower Middle Income Country,Lower-Middle-Income Countries,Middle Income Country,Nation, Less-Developed,Nation, Third-World,Nation, Under-Developed,Third World Countries,Third World Nations,Third-World Country,Third-World Nation,Under Developed Countries,Under Developed Nations,Under-Developed Country,Under-Developed Nation
D004927 Escherichia coli Infections Infections with bacteria of the species ESCHERICHIA COLI. E coli Infections,E. coli Infection,Infections, E coli,Infections, Escherichia coli,E coli Infection,E. coli Infections,Escherichia coli Infection,Infection, E coli,Infection, E. coli,Infection, Escherichia coli
D005658 Fungi A kingdom of eukaryotic, heterotrophic organisms that live parasitically as saprobes, including MUSHROOMS; YEASTS; smuts, molds, etc. They reproduce either sexually or asexually, and have life cycles that range from simple to complex. Filamentous fungi, commonly known as molds, refer to those that grow as multicellular colonies. Fungi, Filamentous,Molds,Filamentous Fungi,Filamentous Fungus,Fungus,Fungus, Filamentous,Mold
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

Roger M Coopoosamy, and Kuben K Naidoo
July 1963, Arzneimittel-Forschung,
Roger M Coopoosamy, and Kuben K Naidoo
April 1986, South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde,
Roger M Coopoosamy, and Kuben K Naidoo
January 2018, Jamba (Potchefstroom, South Africa),
Roger M Coopoosamy, and Kuben K Naidoo
January 2014, Pharmacognosy reviews,
Roger M Coopoosamy, and Kuben K Naidoo
February 1969, Planta medica,
Roger M Coopoosamy, and Kuben K Naidoo
January 1984, Journal of chronic diseases,
Roger M Coopoosamy, and Kuben K Naidoo
April 2014, Journal of ethnopharmacology,
Roger M Coopoosamy, and Kuben K Naidoo
June 1965, Pharmaceutisch weekblad,
Roger M Coopoosamy, and Kuben K Naidoo
August 1967, Planta medica,
Roger M Coopoosamy, and Kuben K Naidoo
August 2019, BMC complementary and alternative medicine,
Copied contents to your clipboard!